Mp83-10 Cd44v8-10 Involves Acquisition of Cisplatin-Resistance in Urothelial Cancer

Journal of Urology - Netherlands
doi 10.1016/j.juro.2016.02.2192
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Stem-Like and Highly Invasive Prostate Cancer Cells Expressing CD44v8-10 Marker Originate From CD44-negative Cells

Oncotarget
Oncology
2018English

Mitigating Cisplatin Resistance in Ovarian Cancer.

English

Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-Vac) in Advanced Urothelial Cancer

Japanese Journal of Urology
Urology
1991English

Cisplatin/Carboplatin Cross-Resistance in Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1989English

Multiple Mechanisms Mediate Resistance to Sorafenib in Urothelial Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2014English

Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer

Clinical Genitourinary Cancer
OncologyUrology
2016English

miR-10 in Development and Cancer

Cell Death and Differentiation
Cell BiologyMolecular Biology
2009English

Mp83-14 Genomic Expression Evidence for Androgen Receptor Axis Activation in Urothelial Carcinoma: Data From the Cancer Genome Atlas

Journal of Urology
Urology
2016English

Prostaglandin Receptors Induce Urothelial Tumourigenesis as Well as Bladder Cancer Progression and Cisplatin Resistance Presumably via Modulating PTEN Expression

British Journal of Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy